Neumora Therapeutics, Inc. (NMRA)

NASDAQ: NMRA · Real-Time Price · USD

1.650

0.00 (0.00%)

At close: Jul 30, 2026, 4:00 PM EDT

1.630

-0.020 (-1.19%)

After-hours: Jul 30, 2026, 5:08 PM EDT

Neumora Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	147.07	182.53	142.15	374.04	240.94	409.25
Short-Term Investments	-	-	165.43	79.94	130.94	-
Cash & Short-Term Investments	147.07	182.53	307.58	453.98	371.88	409.25
Cash Growth	-41.02%	-40.66%	-32.25%	22.08%	-9.13%	113.17%
Other Current Assets	6.36	8.01	6.48	24.3	16.07	6.36
Total Current Assets	153.43	190.54	314.06	478.28	387.96	415.6
Net Property, Plant & Equipment	0.39	0.46	2.92	6.86	10.64	4.04
Long-Term Investments	-	-	-	9.85	23.51	-
Other Long-Term Assets	0.05	0.05	-	1.21	4.13	9.65
Total Assets	153.88	191.05	316.97	496.2	426.23	429.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.06	3.38	3.31	0.34	7.15	1.64
Accrued Expenses	24.77	28.79	24.59	21.26	11.54	19.1
Current Portion of Leases	0.29	0.28	1.85	3.38	3.37	1.06
Other Current Liabilities	-	-	0.13	0.14	1.64	1.49
Total Current Liabilities	30.12	32.45	29.89	25.11	23.7	23.28
Long-Term Debt	52.96	54.53	-	-	-	-
Long-Term Leases	0.12	0.19	-	1.85	5.07	1
Other Long-Term Liabilities	-	-	0.02	0.16	0.63	0.39
Total Long-Term Liabilities	53.08	54.73	0.02	2.01	5.7	1.38
Total Liabilities	83.2	87.18	29.91	27.12	29.4	24.66

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.02	0.02	0.02	0.02	0	0
Additional Paid-in Capital	1,308	1,288	1,234	1,173	21.43	11.38
Accumulated Other Comprehensive Income	-	-	0.06	-0.08	-0.77	-
Retained Earnings	-1,238	-1,184	-947.22	-703.43	-467.51	-336.61
Minority Interest	-	-	-	-	843.69	729.86
Shareholders' Equity	70.68	103.87	287.06	469.08	-446.85	-325.22
Total Liabilities & Equity	153.88	191.05	316.97	496.2	426.23	429.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	53.37	55.01	1.85	5.23	8.44	2.05
Net Cash (Debt)	93.7	127.52	305.73	448.75	363.44	407.2
Net Cash Growth	-62.28%	-58.29%	-31.87%	23.47%	-10.75%	114.39%
Net Cash Per Share	0.56	0.78	1.92	6.90	13.36	18.60
Book Value	70.68	103.87	287.06	469.08	-446.85	-325.22
Book Value Per Share	0.42	0.64	1.80	7.21	-16.42	-14.85
Tangible Book Value	70.68	103.87	287.06	469.08	-446.85	-325.22
Tangible Book Value Per Share	0.42	0.64	1.80	7.21	-16.42	-14.85

SEC Filings: 10-K · 10-Q